Detalhe da pesquisa
1.
Coenzyme Q10 Protects Against Hyperlipidemia-Induced Osteoporosis by Improving Mitochondrial Function via Modulating miR-130b-3p/PGC-1α Pathway.
Calcif Tissue Int
; 114(2): 182-199, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055044
2.
Three-dimensional-printed MPBI@ß-TCP scaffold promotes bone regeneration and impedes osteosarcoma under near-infrared laser irradiation.
FASEB J
; 37(5): e22924, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071462
3.
Tislelizumab with gemcitabine and oxaliplatin in patients with relapsed or refractory classic Hodgkin lymphoma: a multicenter phase II trial.
Haematologica
; 108(8): 2146-2154, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36700408
4.
Anti-Postmenopausal osteoporosis effects of Isopsoralen: A bioinformatics-integrated experimental study.
Phytother Res
; 37(1): 231-251, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36123318
5.
Aberrant SPOP-CHAF1A ubiquitination axis triggers tumor autophagy that endows a therapeutical vulnerability in diffuse large B cell lymphoma.
J Transl Med
; 20(1): 296, 2022 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35773729
6.
Mucin 20 modulates proteasome capacity through c-Met signalling to increase carfilzomib sensitivity in mantle cell lymphoma.
J Cell Mol Med
; 25(21): 10164-10174, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34651428
7.
Extracellular vesicles carrying miRNA-181b-5p affects the malignant progression of acute lymphoblastic leukemia.
J Transl Med
; 19(1): 511, 2021 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34922585
8.
Watch-and-wait or immediate immunotherapy/immunochemotherapy in patients with phase IE primary pulmonary MALT lymphoma? A multicenter retrospective study.
Ann Hematol
; 100(3): 709-714, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33483774
9.
Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes.
Haematologica
; 109(2): 666-670, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37706332
10.
Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway.
Mol Cell Biochem
; 433(1-2): 141-148, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28405849
11.
The effect of S1P receptor signaling pathway on the survival and drug resistance in multiple myeloma cells.
Mol Cell Biochem
; 424(1-2): 185-193, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27785703
12.
Live kinase B1 maintains CD34+CD38- AML cell proliferation and self-renewal.
Mol Cell Biochem
; 434(1-2): 25-32, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28397012
13.
Down-regulation of long non-coding RNA MALAT1 by RNA interference inhibits proliferation and induces apoptosis in multiple myeloma.
Clin Exp Pharmacol Physiol
; 44(10): 1032-1041, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664617
14.
The Nuclear Factor (Erythroid-derived 2)-like 2 and Proteasome Maturation Protein Axis Mediate Bortezomib Resistance in Multiple Myeloma.
J Biol Chem
; 290(50): 29854-68, 2015 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483548
15.
MUC20 regulated by extrachromosomal circular DNA attenuates proteasome inhibitor resistance of multiple myeloma by modulating cuproptosis.
J Exp Clin Cancer Res
; 43(1): 68, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439082
16.
MicroRNA Let-7i Regulates Innate TLR4 Pathways in Peripheral Blood Mononuclear Cells of Patients with Ankylosing Spondylitis.
Int J Gen Med
; 16: 1393-1401, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37155468
17.
The 10-m cotton maps in Xinjiang, China during 2018-2021.
Sci Data
; 10(1): 688, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37816768
18.
A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
Lancet Reg Health West Pac
; 34: 100720, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37283978
19.
Immunophenotype of Chinese patients with T-lineage acute lymphoblastic leukemia and its association to biological and clinical features.
Acta Haematol
; 127(4): 199-204, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22456344
20.
The proteasome inhibitor bortezomib reverses P-glycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway.
Pharmazie
; 67(2): 187-92, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22512091